The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in high risk, poorly controlled pediatric Type 1 diabetes patients increases uptake of personal CGM use, and improves short-term time in range glucose control.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
26
Eligible patients will have a Dexcom G6 Continuous Glucose Monitor placed for 10 days.
Johns Hopkins Pediatric Diabetes Center
Baltimore, Maryland, United States
Change in Personal CGM Use
Evaluate whether there is any change in uptake of personal CGM after 10-day trial.
Time frame: Baseline and 3 months
Change in the Percent Time in Range Glucose Control
Changes in time in range glucose control from 1-5 days to 6-10 days from the Dexcom CGM
Time frame: 1-5 days and 6-10 days
Change in Hemoglobin A1c
Changes in HbA1c from baseline to next available A1c at 3-6 month follow up visit
Time frame: Baseline, 3-6 months
Using Personal CGM
Percentage of participants using CGM at time of follow up, of those who reported wanting a personal CGM
Time frame: 3-6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.